Full-Time

Principal Servicenow Developer

Confirmed live in the last 24 hours

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$127.5k - $184.8kAnnually

+ Bonus + Equity Incentive Program

Senior, Expert

San Diego, CA, USA

Category
Backend Engineering
Software Engineering
Required Skills
Microsoft Azure
Agile
ServiceNow
AWS
Google Cloud Platform
Requirements
  • Bachelor’s degree (BS/BA) in Computer Science, Engineering, or a related discipline, with 6+ years of relevant experience, OR
  • Master’s degree in a related field with 4+ years of relevant experience, OR
  • 6+ years of equivalent work experience in ServiceNow development and administration without a degree
  • ServiceNow Certified System Administrator (CSA)
  • ServiceNow Certified Application Developer (CAD)
  • ServiceNow Certified Implementation Specialist (CIS) in relevant modules (ITSM, ITOM, HRSD, etc.)
  • ServiceNow Certified Application Specialist (CAS)
  • Cloud Certifications (AWS, Azure, GCP)
  • Agile/ITIL Certifications
Responsibilities
  • Take ownership of the full software development lifecycle, including requirement analysis, design, coding, testing, and deployment of ServiceNow applications and integrations.
  • Design scalable, robust, and innovative ServiceNow solutions that align with business needs and technical requirements. Guide the architecture and implementation of core ITSM processes, custom applications, and integrations.
  • Provide deep expertise in ServiceNow modules such as ITSM, ITOM, ITBM, SecOps, HRSD, and others. Stay up to date with new features, functionalities, and best practices in ServiceNow.
  • Mentor and lead a team of ServiceNow developers, offering guidance and support in code reviews, troubleshooting, and problem-solving. Foster a culture of continuous learning and improvement within the team.
  • Work closely with stakeholders to identify opportunities for process improvements and automation using the ServiceNow platform. Ensure that solutions are efficient, maintainable, and aligned with business goals.
  • Develop and maintain integrations between ServiceNow and other enterprise systems, ensuring data consistency and smooth operation across platforms.
  • Ensure all ServiceNow solutions adhere to security standards and regulatory requirements. Implement access controls, encryption, and other security measures as needed.
  • Create and maintain comprehensive documentation for all customizations, configurations, and workflows. Provide training and support to end-users and other developers as necessary.
  • Monitor the performance and health of the ServiceNow platform, identifying and resolving any issues proactively to ensure optimal performance.
  • Collaborate with IT leadership, business analysts, and other stakeholders to understand business needs and translate them into technical solutions on the ServiceNow platform.
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 2 data for NBI-1117568 in schizophrenia and the launch of INGREZZA SPRINKLE highlight Neurocrine's innovative pipeline and commitment to addressing unmet medical needs.
  • The FDA's acceptance of crinecerfont's New Drug Applications with Priority Review could lead to a significant market breakthrough if approved.
  • Recent investments and executive appointments suggest strong confidence in the company's future growth and strategic direction.

What critics are saying

  • The pharmaceutical industry is highly competitive, and Neurocrine must continuously innovate to maintain its market position.
  • Regulatory hurdles, such as FDA rejections, could delay product launches and impact financial performance.

What makes Neurocrine Biosciences unique

  • Neurocrine Biosciences is pioneering in the treatment of congenital adrenal hyperplasia (CAH) with crinecerfont, a first-in-class therapy that hasn't seen innovation in 70 years.
  • The company offers unique formulations like INGREZZA SPRINKLE, addressing specific patient needs such as dysphagia, which sets them apart in the pharmaceutical landscape.
  • Their focus on rare and serious endocrine disorders, combined with successful clinical trials, positions them as a leader in niche therapeutic areas.

Help us improve and share your feedback! Did you find this helpful?